• Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Dividend Stocks Report
No Result
View All Result
Home Stock News

Hedge-fund investor who made $2.6 billion on pandemic trades says omicron could be bullish for stock market

by
November 29, 2021
in Stock News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Hedge-fund luminary Bill Ackman over the weekend said the new omicron variant of the coronavirus that causes COVID-19 could be bullish for stocks if it proves to result in mild to moderate symptoms for those who contract it.

Related Posts

Judge allows Dominion’s $1.6 billion defamation lawsuit against Fox to go to trial

Trump campaign uses newly restored Facebook page to fundraise off indictment

Millions will start losing Medicaid coverage as Covid safety net is dismantled

Schwab Hit by Worst Month Since 1987 Amid Cash Sorting Woes

The discovery of the variant resulted in one of the worst Black Friday trading sessions in recent memory, with the Dow Jones Industrial Average
DJIA,
the S&P 500 index
SPX
and the Nasdaq Composite Index
COMP
all tumbling by at least 2%, but Ackman’s comments suggest that investors’ knee-jerk response may have been an overreaction.

Bond yields on Friday also fell as prices for government debt saw a rush to the perceived safety of Treasurys on the back of fresh concerns about new restrictions that could result from a strain of COVID that the World Health Organization on Friday designated a variant of concern.

However, stocks were bouncing back on Monday and the 10-year Treasury note yield
BX:TMUBMUSD10Y
was up 8 basis points at 1.56%. Prices for Treasurys fall as yields rise.

Ackman, who runs Pershing Square Capital, is known for his lucrative COVID wager. The Financial Times reported back in 2020 that the investor cashed out on bet that netted him a $2.6 billion profit on a $27 million at risk, on the premise that insurance premiums would soar during the height of the 2020 COVID pandemic as economies locked down.

He also later in 2020 said that he placed bearish bets on corporate credit on the day that Pfizer
PFE
 and BioNTech
BNTX
released positive trial data on their COVID-19 vaccine, which triggered a whipsaw rally in stocks.

Ackman was wagering that the vaccines would lead to mask-wearing complacency. However, that bet presumably turned out wrong as markets continued to surge in the aftermath of those vaccines.

The danger posed by the omicron variant isn’t yet fully understood, even though governments in Europe, Asia, the Middle East and the Americas immediately restricted travel from southern Africa.

Vaccine manufacturers have said that they are examining the variant closely and note that the current batch of remedies might still prove effective against the strain and new vaccines could be readied in early 2022 if needed.

Next Post

Biden says he doesn't expect more travel restrictions or lockdowns as Covid omicron variant spreads

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Stock News

Trump campaign uses newly restored Facebook page to fundraise off indictment

by
March 31, 2023
0

In this article META Follow your favorite stocksCREATE FREE ACCOUNT An advertisement soliciting donations for former U.S. President Donald Trump...

Read more

Trump campaign uses newly restored Facebook page to fundraise off indictment

Judge allows Dominion’s $1.6 billion defamation lawsuit against Fox to go to trial

Millions will start losing Medicaid coverage as Covid safety net is dismantled

Schwab Hit by Worst Month Since 1987 Amid Cash Sorting Woes

The Newest ‘Bubble’ Is in Money-Market Funds

GE Stock Breaks Out To New High After Soaring More Than 45% — Is It A Buy?

Load More

All rights reserved by www.dividendstocksreport.net

  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.